Investigación / Grupos de investigación

Grupo  1

Inflamación y Daño Vascular en la Enfermedad Renal Crónica, Diálisis y Trasplante Renal. Fisiopatología renal

Publicaciones (303)

  • Goicoechea, M; Quiroga, B; de Vinuesa, SG; Verdalles, U; Reque, J; Panizo, N; Arroyo, D; Santos, A; Macias, N; Luno, J.

    Intraindividual Interleukin-6 Variations on the Cardiovascular Prognosis of Patients with Chronic Renal Disease

    RENAL FAILURE. 2012; 34(8): 1002-1009 Nº de citas: 25 [doi:10.3109/0886022X.2012.696469]

  • Arroyo, D; Panizo, N; de Vinuesa, SG; Goicoechea, M; Verdalles, U; Luno, J.

    Hypercalcemia as a side effect of potassium binding agents

    NEFROLOGIA. 2012; 32(5): 655-658 Nº de citas: 9 [doi:10.3265/Nefrologia.pre2012.Jun.11500]

  • Moreno-Gordaliza, E; Esteban-Fernandez, D; Giesen, C; Lehmann, K; Lazaro, A; Tejedor, A; Scheler, C; Canas, B; Jakubowski, N; Linscheid, MW; Gomez-Gomez, MM.

    LA-ICP-MS and nHPLC-ESI-LTQ-FT-MS/MS for the analysis of cisplatin-protein complexes separated by two dimensional gel electrophoresis in biological samples

    J ANAL ATOM SPECTROM. 2012; 27(9): 1474-1483 Nº de citas: 34 [doi:10.1039/c2ja30016h]

  • Perez-Garcia, R; Palomares-Sancho, I; Merello-Godino, JI; Aljama-Garcia, P; Bustamante-Bustamante, J; Luno, J; Maduell-Canals, F; Martin-de Francisco, AL; Martin-Malo, A; Mirapeix-i-Vicens, E; Molina-Nunez, M; Praga-Terente, M; Tetta, C; Marcelli, D.

    Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD (R) database: results from years 2009-2010

    NEFROLOGIA. 2012; 32(6): 743-753 Nº de citas: 19 [doi:10.3265/Nefrologia.pre2012.Jul.11549]

  • Moreno-Gordaliza, E; Giesen, C; Lazaro, A; Esteban-Fernandez, D; Humanes, B; Canas, B; Panne, U; Tejedor, A; Jakubowski, N; Gomez-Gomez, MM.

    Elemental Bioimaging in Kidney by LA-ICP-MS As a Tool to Study Nephrotoxicity and Renal Protective Strategies in Cisplatin Therapies

    ANAL CHEM. 2011; 83(20): 7933-7940 Nº de citas: 133 [doi:10.1021/ac201933x]

  • Martinez-Castelao, A; Gorriz, JL; Portoles, JM; De Alvaro, F; Cases, A; Luno, J; Navarro-Gonzalez, JF; Montes, R; De la Cruz-Troca, JJ; Natarajan, A; Batlle, D.

    Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study

    BMC Nephrology. 2011; 12: Nº de citas: 65 [doi:10.1186/1471-2369-12-53]

  • Trullas, JC; Cofan, F; Barril, G; Martinez-Castelao, A; Jofre, R; Rivera, M; Martinez-Ara, J; Ros, S; Perez, I; Moreno, A; Miro, JM.

    Outcome and Prognostic Factors in HIV-1-Infected Patients on Dialysis in the cART Era: a GESIDA/SEN Cohort Study

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011; 57(4): 276-283 Nº de citas: 55 [doi:10.1097/QAI.0b013e318221fbda]

  • Arroyo D; Melero R; Panizo N; Goicoechea M; Rodríguez-Benítez P; Vinuesa SG; Verde E; Tejedor A; Luño J.

    Metformin-associated acute kidney injury and lactic acidosis.

    International Journal of Nephrology. 2011; 2011: 749653-749653 [doi:10.4061/2011/749653]

  • Lledo-Garcia, E; Subira-Rios, D; Ogaya-Pinies, G; Tejedor-Jorge, A; Del Canizo-Lopez, JF; Hernandez-Fernandez, C.

    Intravenous Sildenafil as a Preconditioning Drug Against Hemodynamic Consequences of Warm Ischemia-Reperfusion on the Kidney

    J UROLOGY. 2011; 186(1): 331-333 Nº de citas: 14 [doi:10.1016/j.juro.2011.03.036]

  • Puente-Maestu, L; Lazaro, A; Tejedor, A; Camano, S; Fuentes, M; Cuervo, M; Navarro, BO; Agusti, A.

    Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD

    THORAX. 2011; 66(2): 121-127 Nº de citas: 59 [doi:10.1136/thx.2010.153031]

  • Lledo-Garcia, E; Subira-Rios, D; Tejedor-Jorge, A; del Canizo-Lopez, JF; Hernandez-Fernandez, C.

    Optimizing Outcomes by Preconditioning the Donor

    TRANSPLANTATION PROCEEDINGS. 2011; 43(1): 349-352 Nº de citas: 4 [doi:10.1016/j.transproceed.2010.12.020]

  • Abad, S; Sotomayor, G; Vega, A; de Jose, AP; Verdalles, U; Jofre, R; Lopez-Gomez, JM.

    The phase angle of the electrical impedance is a predictor of long-term survival in dialysis patients

    NEFROLOGIA. 2011; 31(6): 670-676 Nº de citas: 66 [doi:10.3265/Nefrologia.pre2011.Sep.10999]

  • Verdalles, U; Abad, S; Vega, A; Caro, CR; Ampuero, J; Jofre, R; Lopez-Gomez, JM.

    Factors Related to the Absence of Anemia in Hemodialysis Patients

    BLOOD PURIFICATION. 2011; 32(1): 69-74 Nº de citas: 20 [doi:10.1159/000323095]

  • Goicoechea M; Álvarez V; Segarra A; Polaina M; Martín-Reyes G; Robles NR; Escudero V; Orellana C; Bea Granell S; de Juan-Ribera J; Fernández Lucas M; Graña JM; Reque J; Sánchez Hernández R; Villamayor S; Górriz JL.

    Lipid profile of patients treated with evolocumab in Spanish hospital nephrology units (RETOSS NEFRO).

    Nefrologia. ; : [doi:10.1016/j.nefro.2021.06.004]

  • Salgueira M; Almenara M; Gutierrez-Pizarraya A; Belmar L; Labrador PJ; Melero R; Serrano ML; Portolés JM; Molina A; Poch E; Ramos N; Lloret MJ; Echarri R; Díaz Mancebo R; González-Lara DM; Sánchez JE; Soler MJ.

    Caracterización de la población con fracaso renal agudo durante la hospitalización por COVID-19 en España: tratamiento renal sustitutivo y mortalidad. Datos del Registro FRA-COVID SEN.

    NEFROLOGIA. ; : [doi:10.1016/j.nefro.2023.03.008]